Cargando…

Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles

Extracellular vesicles (EVs) have great potential as drug delivery vehicles. While mesenchymal/stromal stem cell (MSC) conditioned medium (CM) and milk are potentially safe and scalable sources of EVs for this purpose, the suitability of MSC EVs and milk EVs as drug delivery vehicles has never been...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhopadhya, Anindya, Tsiapalis, Dimitrios, McNamee, Niamh, Talbot, Brian, O’Driscoll, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051717/
https://www.ncbi.nlm.nih.gov/pubmed/36986579
http://dx.doi.org/10.3390/pharmaceutics15030718
_version_ 1785014956488392704
author Mukhopadhya, Anindya
Tsiapalis, Dimitrios
McNamee, Niamh
Talbot, Brian
O’Driscoll, Lorraine
author_facet Mukhopadhya, Anindya
Tsiapalis, Dimitrios
McNamee, Niamh
Talbot, Brian
O’Driscoll, Lorraine
author_sort Mukhopadhya, Anindya
collection PubMed
description Extracellular vesicles (EVs) have great potential as drug delivery vehicles. While mesenchymal/stromal stem cell (MSC) conditioned medium (CM) and milk are potentially safe and scalable sources of EVs for this purpose, the suitability of MSC EVs and milk EVs as drug delivery vehicles has never been compared and so was the objective of this study. Here EVs were separated from MSCs’ CM and from milk and were characterised by nanoparticle tracking analysis, transmission electron microscopy, total protein quantification, and immunoblotting. An anti-cancer chemotherapeutic drug, doxorubicin (Dox), was then loaded into the EVs by one of three methods: by passive loading or by active loading by either electroporation or sonication. Dox-loaded EVs were analysed by fluorescence spectrophotometer, high-performance liquid chromatography (HPLC), and imaging flow cytometer (IFCM). Our study showed that EVs were successfully separated from the milk and MSC CM, with significantly (p < 0.001) higher yields of milk EVs/mL starting material compared to MSC EVs/mL of starting material. Using a fixed amount of EVs for each comparison, electroporation achieved significantly more Dox loading when compared to passive loading (p < 0.01). Indeed, of 250 µg of Dox made available for loading, electroporation resulted in 90.1 ± 12 µg of Dox loading into MSC EVs and 68.0 ± 10 µg of Dox loading into milk EVs, as analysed by HPLC. Interestingly, compared to the passive loading and electroporation approach, after sonication significantly fewer CD9+ EVs/mL (p < 0.001) and CD63+ EVs/mL (p < 0.001) existed, as determined by IFCM. This observation indicates that sonication, in particular, may have detrimental effects on EVs. In conclusion, EVs can be successfully separated from both MSC CM and milk, with milk being a particularly rich source. Of the three methods tested, electroporation appears to be superior for achieving maximum drug loading while not causing damage to EV surface proteins.
format Online
Article
Text
id pubmed-10051717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100517172023-03-30 Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles Mukhopadhya, Anindya Tsiapalis, Dimitrios McNamee, Niamh Talbot, Brian O’Driscoll, Lorraine Pharmaceutics Article Extracellular vesicles (EVs) have great potential as drug delivery vehicles. While mesenchymal/stromal stem cell (MSC) conditioned medium (CM) and milk are potentially safe and scalable sources of EVs for this purpose, the suitability of MSC EVs and milk EVs as drug delivery vehicles has never been compared and so was the objective of this study. Here EVs were separated from MSCs’ CM and from milk and were characterised by nanoparticle tracking analysis, transmission electron microscopy, total protein quantification, and immunoblotting. An anti-cancer chemotherapeutic drug, doxorubicin (Dox), was then loaded into the EVs by one of three methods: by passive loading or by active loading by either electroporation or sonication. Dox-loaded EVs were analysed by fluorescence spectrophotometer, high-performance liquid chromatography (HPLC), and imaging flow cytometer (IFCM). Our study showed that EVs were successfully separated from the milk and MSC CM, with significantly (p < 0.001) higher yields of milk EVs/mL starting material compared to MSC EVs/mL of starting material. Using a fixed amount of EVs for each comparison, electroporation achieved significantly more Dox loading when compared to passive loading (p < 0.01). Indeed, of 250 µg of Dox made available for loading, electroporation resulted in 90.1 ± 12 µg of Dox loading into MSC EVs and 68.0 ± 10 µg of Dox loading into milk EVs, as analysed by HPLC. Interestingly, compared to the passive loading and electroporation approach, after sonication significantly fewer CD9+ EVs/mL (p < 0.001) and CD63+ EVs/mL (p < 0.001) existed, as determined by IFCM. This observation indicates that sonication, in particular, may have detrimental effects on EVs. In conclusion, EVs can be successfully separated from both MSC CM and milk, with milk being a particularly rich source. Of the three methods tested, electroporation appears to be superior for achieving maximum drug loading while not causing damage to EV surface proteins. MDPI 2023-02-21 /pmc/articles/PMC10051717/ /pubmed/36986579 http://dx.doi.org/10.3390/pharmaceutics15030718 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mukhopadhya, Anindya
Tsiapalis, Dimitrios
McNamee, Niamh
Talbot, Brian
O’Driscoll, Lorraine
Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title_full Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title_fullStr Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title_full_unstemmed Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title_short Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles
title_sort doxorubicin loading into milk and mesenchymal stem cells’ extracellular vesicles as drug delivery vehicles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051717/
https://www.ncbi.nlm.nih.gov/pubmed/36986579
http://dx.doi.org/10.3390/pharmaceutics15030718
work_keys_str_mv AT mukhopadhyaanindya doxorubicinloadingintomilkandmesenchymalstemcellsextracellularvesiclesasdrugdeliveryvehicles
AT tsiapalisdimitrios doxorubicinloadingintomilkandmesenchymalstemcellsextracellularvesiclesasdrugdeliveryvehicles
AT mcnameeniamh doxorubicinloadingintomilkandmesenchymalstemcellsextracellularvesiclesasdrugdeliveryvehicles
AT talbotbrian doxorubicinloadingintomilkandmesenchymalstemcellsextracellularvesiclesasdrugdeliveryvehicles
AT odriscolllorraine doxorubicinloadingintomilkandmesenchymalstemcellsextracellularvesiclesasdrugdeliveryvehicles